Sargent Bickham Lagudis’s Epizyme, Inc EPZM Stock Holding History

Sargent Bickham Lagudis’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-500	Closed	-$1K	–	1167
2022 Q2	$1K	Hold	500	–	–	﹤0.01%	1041
2022 Q1	$1K	Hold	500	–	–	﹤0.01%	946
2021 Q4	$1K	Hold	500	–	–	﹤0.01%	946
2021 Q3	$3K	Hold	500	–	–	﹤0.01%	876
2021 Q2	$4K	Hold	500	–	–	﹤0.01%	831
2021 Q1	$4K	Hold	500	–	–	﹤0.01%	826
2020 Q4	$5K	Buy	+500	New	+$6.17K	﹤0.01%	750

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Sargent Bickham Lagudis's EPZM Position: Q3 2022 in Review

Sargent Bickham Lagudis sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 500 shares — an estimated $1K sold.

Sargent Bickham Lagudis first reported a position in EPZM in Q4 2020 and held it in 7 quarters. The position peaked at $5K in Q4 2020. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Sargent Bickham Lagudis reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Sargent Bickham Lagudis sold 500 Epizyme, Inc shares in Q3 2022, an estimated $1K.
Sargent Bickham Lagudis first reported a position in Epizyme, Inc in Q4 2020 and held it in 7 quarters.
Sargent Bickham Lagudis's Epizyme, Inc position peaked at $5K in Q4 2020.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2022, filed 27 Oct 2022.